Thy, S., Hommel, A., Meneceur, S., Bartkowiak, A. L., Schulz, W. A., Niegisch, G., & Hoffmann, M. J. (2021). Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment. Cancers (Basel).

Thy, Sophia, Alexandra Hommel, Sarah Meneceur, Anna L. Bartkowiak, Wolfgang A. Schulz, Günter Niegisch, and Michèle J. Hoffmann. "Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment." Cancers (Basel) 2021.

Thy, Sophia, et al. "Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment." Cancers (Basel) 2021.